Cargando…
COVID‐19 pneumonia and pulmonary microembolism in a patient with B‐thalassemia major
We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID‐19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications.
Autores principales: | Marziali, Marco, Ribersani, Michela, Losardo, Anna Annunziata, Taglietti, Fabrizio, Pugliese, Pellegrina, Micozzi, Alessandra, Gentile, Giuseppe, Angeloni, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646639/ https://www.ncbi.nlm.nih.gov/pubmed/33173583 http://dx.doi.org/10.1002/ccr3.3275 |
Ejemplares similares
-
Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients
por: Anastasi, Emanuela, et al.
Publicado: (2022) -
Experimental pulmonary microembolism: effects on hemodynamics, lung mechanics and histopathology
por: Azevedo, LCP, et al.
Publicado: (2007) -
Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia
por: Isgro’, Antonella, et al.
Publicado: (2017) -
Cutaneous Microembolism of Fingers and Toes
por: Wollina, Uwe, et al.
Publicado: (2018) -
Tumor Microembolism to Alveolar Capillaries
por: Kinoshita, Yoshiaki, et al.
Publicado: (2019)